GSK N25, Moscow

Accounting reports

Previously

Name	Garazhno-stroitel'nyy kooperativ N 25 RAYONA CHERTANOVO SEVERNOE YUAO G.MOSKVY
INN	7726190989
KPP	772601001
OGRN	1027739928380
OKPO	43315843
Address	117525, gorod Moskva, ul. Dnepropetrovskaya, d. D. 12A
Phone	+7 (495) 317-23-05

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities GSK N25 according to EGRUL
52.21.24	Core activity	Activities of Parking for vehicles

Registration information

Registration date	30.12.2002
Registering department	MEZHRAYONNAYA INSPEKTSIYA MNS ROSSII 39 PO G MOSKVE

Description

GSK N25 (Moscow; INN 7726190989) was registered on 30 Dec 2002. Type of ownership of GSK N25 - Comsumer cooperatives.

Form of ownership of GSK N25 - Private property.

Principal activities of GSK N25: activities of parking for vehicles (52.21.24).

Industry

52 - Warehousing and storage
- 52.2 - Service activities incidental to land transportation
  - 52.21 - Other service activities for land transport
    - 52.21.2 - Activities auxiliary relating to road transport
      - 52.21.24 - Activities of Parking for vehicles

Economic indicators

2021

Net profit (RAS) of GSK N25 dropped in 2021 by 43.49% to 382.00 thousand RUB from 676.00 thousand RUB over the same period in 2020, the company informed.

Revenue decreased in the accounting period 3.38 times to 3.89 million RUB from 13.18 million RUB in 2020.

2020

Net profit (RAS) of GSK N25 grew over 2020 2.28 times to 676.00 thousand RUB from 296.00 thousand RUB over 2019, the company informed.

Revenue increased in the accounting period by 1.77% to 13.18 million RUB from 12.95 million RUB over 2019.

2019

Net profit (RAS) of GSK N25 dropped in 2019 2.79 times to 296.00 thousand RUB from 825.00 thousand RUB over the same period in 2018, the company informed.

Revenue increased in the accounting period by 0.79% to 12.95 million RUB from 12.85 million RUB over 2018.

2018

Net profit (RAS) of GSK N25 dropped in 2018 by 3.51% to 825.00 thousand RUB from 855.00 thousand RUB over the same period in 2017, the company informed.

Revenue increased in the accounting period by 2.37% to 12.85 million RUB from 12.55 million RUB over 2017; cost of goods sold grew by 2.80% to 12.02 million RUB from 11.70 million RUB; sales profit fell by 3.51% to 825.00 thousand RUB from 855.00 thousand RUB.

2017

Net profit (RAS) of GSK N25 grew over 2017 1.78 times to 855.00 thousand RUB from 479.00 thousand RUB over 2016, the company informed.

Revenue increased in the accounting period by 11.12% to 12.55 million RUB from 11.30 million RUB over 2016; cost of goods sold grew by 8.14% to 11.70 million RUB from 10.82 million RUB; sales profit went up 1.78 times to 855.00 thousand RUB from 479.00 thousand RUB.

2016

Net profit (RAS) of GSK N25 dropped in 2016 by 38.35% to 479.00 thousand RUB from 777.00 thousand RUB over the same period in 2015, the company informed.

Revenue remained in the accounting period at the same level and made up 11.30 million RUB compared to 11.28 million RUB 11.28 million RUB; cost of goods sold grew by 2.94% to 10.82 million RUB from 10.51 million RUB; sales profit fell by 38.35% to 479.00 thousand RUB from 777.00 thousand RUB.

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 334 717

Reports

17 430 612

Rrocessed requests

Extract from EGRUL:

Today, 4:23 PM

Accounting reports:

Today, 4:21 PM